Immunotherapy for Prostate Cancer: Biology and Therapeutic Approaches

Por Cha, Edward, Fong, Lawrence
Publicado em 2011

Effects of RANKL-Targeted Therapy in Immunity and Cancer

Por Cheng, Michael L., Fong, Lawrence
Publicado em 2014

Neoadjuvant therapy for localized prostate cancer: Examining mechanism of action and efficacy within the tumor

Por Lou, David Y., Fong, Lawrence
Publicado no Urol Oncol (2014)

Beyond Sipuleucel-T: Immune Approaches to Treating Prostate Cancer

Por Cheng, Michael L., Fong, Lawrence
Publicado no Curr Treat Options Oncol (2014)

Unmasking the immune recognition of prostate cancer with CTLA4 blockade

Por Kwek, Serena S., Cha, Edward, Fong, Lawrence
Publicado em 2012

Interplay between CD8α(+) Dendritic Cells and Monocytes in Response to Listeria monocytogenes Infection Attenuates T Cell Responses

Por Kapadia, Dilnawaz, Sadikovic, Aida, Vanloubbeeck, Yannick, Brockstedt, Dirk, Fong, Lawrence
Publicado em 2011

Immunotherapy in Genitourinary Malignancies

Por Wattenberg, Max, Fong, Lawrence, Madan, Ravi A., Gulley, James L.
Publicado no Curr Opin Urol (2016)

3D: diversity, dynamics, differential testing – a proposed pipeline for analysis of next-generation sequencing T cell repertoire data

Por Zhang, Li, Cham, Jason, Paciorek, Alan, Trager, James, Sheikh, Nadeem, Fong, Lawrence
Publicado no BMC Bioinformatics (2017)

Productive Infection of Plasmacytoid Dendritic Cells with Human Immunodeficiency Virus Type 1 Is Triggered by CD40 Ligation

Por Fong, Lawrence, Mengozzi, Manuela, Abbey, Nancy W., Herndier, Brian G., Engleman, Edgar G.
Publicado em 2002

Improved Survival with T Cell Clonotype Stability After Anti–CTLA-4 Treatment in Cancer Patients

Por Cha, Edward, Klinger, Mark, Hou, Yafei, Cummings, Craig, Ribas, Antoni, Faham, Malek, Fong, Lawrence
Publicado no Sci Transl Med (2014)

Phase I-II study of ADXS31-142 alone and in combination with pembrolizumab in patients with previously treated metastatic castration-resistant prostate cancer (mCRPC): the KEYNOTE-...

Por Haas, Naomi B, Stein, Mark N, Tutrone, Ronald, Perini, Rodolfo, Denker, Andrew, Mauro, David, Fong, Lawrence
Publicado no J Immunother Cancer (2015)

Immune toxicities elicted by CTLA-4 blockade in cancer patients are associated with early diversification of the T cell repertoire

Por Oh, David Y., Cham, Jason, Zhang, Li, Fong, Grant, Kwek, Serena S., Klinger, Mark, Faham, Malek, Fong, Lawrence
Publicado no Cancer Res (2016)

SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade

Por Fassò, Marcella, Waitz, Rebecca, Hou, Yafei, Rim, Tae, Greenberg, Norman M., Shastri, Nilabh, Fong, Lawrence, Allison, James P.
Publicado em 2008

Diversity of antigen-specific responses induced in vivo with CTLA-4 blockade in prostate cancer patients

Por Kwek, Serena S., Dao, Vinh, Roy, Ritu, Hou, Yafei, Alajajian, David, Simko, Jeffrey P., Small, Eric J., Fong, Lawrence
Publicado em 2012

Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy

Por Fong, Lawrence, Hou, Yafei, Rivas, Alberto, Benike, Claudia, Yuen, Alan, Fisher, George A., Davis, Mark M., Engleman, Edgar G.
Publicado em 2001

An aberrant prostate antigen–specific immune response causes prostatitis in mice and is associated with chronic prostatitis in humans

Por Hou, Yafei, DeVoss, Jason, Dao, Vinh, Kwek, Serena, Simko, Jeffrey P., McNeel, Douglas G., Anderson, Mark S., Fong, Lawrence
Publicado em 2009

CTLA4 blockade expands FoxP3(+) regulatory and activated effector CD4(+) T cells in a dose-dependent fashion

Por Kavanagh, Brian, O'Brien, Shaun, Lee, David, Hou, Yafei, Weinberg, Vivian, Rini, Brian, Allison, James P., Small, Eric J., Fong, Lawrence
Publicado em 2008

HLA-A2-Restricted T-Cell Epitopes Specific for Prostatic Acid Phosphatase

Por Olson, Brian M., Frye, Thomas P., Johnson, Laura E., Fong, Lawrence, Knutson, Keith L., Disis, Mary L., McNeel, Douglas G.
Publicado em 2010

Pre-existing levels of CD4 T cells expressing PD-1 are related to overall survival in prostate cancer patients treated with ipilimumab

Por Kwek, Serena S., Lewis, Jera, Zhang, Li, Weinberg, Vivian, Greaney, Samantha, Harzstark, Andrea, Lin, Amy, Ryan, Charles, Small, Eric J., Fong, Lawrence
Publicado no Cancer Immunol Res (2015)

Spontaneous autoimmunity prevented by thymic expression of a single self-antigen

Por DeVoss, Jason, Hou, Yafei, Johannes, Kellsey, Lu, Wen, Liou, Gregory I., Rinn, John, Chang, Howard, Caspi, Rachel, Fong, Lawrence, Anderson, Mark S.
Publicado em 2006